Skip to main content

Diagnostic Evaluation of Usual Ductal Hyperplasia and Atypical Ductal Hyperplasia

  • Chapter
  • First Online:
Practical Atlas of Breast Pathology

Abstract

Ductal hyperplasia of the breast is an intraductal proliferation of epithelial cells that is subdivided into two diagnostic categories: usual ductal hyperplasia and atypical ductal hyperplasia. Usual ductal hyperplasia represents a non-neoplastic proliferation that is commonly encountered as a component of fibrocystic changes. Atypical ductal hyperplasia, on the other hand, represents a neoplastic proliferation that shares cytologic and architectural features with ductal carcinoma in situ. Accurate differentiation between these two forms of ductal hyperplasia is important for patient management and breast cancer risk assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–37.

    Article  CAS  PubMed  Google Scholar 

  2. Jabbar SB, Lynch B, Seiler S, Hwang H, Sahoo S. Pathologic findings of breast lesions detected on magnetic resonance imaging. Arch Pathol Lab Med. 2017;141:1513–22.

    Article  PubMed  Google Scholar 

  3. Boecker W, Moll R, Dervan P, Buerger H, Poremba C, Diallo RI, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in-situ. J Pathol. 2002;198:458–67.

    Article  PubMed  Google Scholar 

  4. Otterbach F, Bànkfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology. 2000;37:232–40.

    Article  CAS  PubMed  Google Scholar 

  5. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698–708.

    Article  CAS  PubMed  Google Scholar 

  6. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the nurses’ health study. Cancer. 2006;107:1240–7.

    Article  PubMed  Google Scholar 

  7. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010;57:171–92.

    Article  PubMed  Google Scholar 

  8. Simpson JF. Update on atypical epithelial hyperplasia and ductal carcinoma in situ. Pathology. 2009;41:36–9.

    Article  PubMed  Google Scholar 

  9. Mooney KL, Bassett LW, Apple SK. Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 2016;29:1471–84.

    Article  CAS  PubMed  Google Scholar 

  10. Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila). 2014;7:211–7.

    Article  CAS  Google Scholar 

  11. Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast – risk assessment and management options. N Engl J Med. 2015;372:78–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012;136:627–33.

    Article  CAS  PubMed  Google Scholar 

  13. Smith SG, Sestak I, Forster A, Partridge A, Side L, Wolf MS, et al. Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol. 2016;27:575–90.

    Article  CAS  PubMed  Google Scholar 

  14. Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson AN, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015;313:1122–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65:518–29.

    Article  CAS  PubMed  Google Scholar 

  16. Schnitt SJ, Collins LC. Intraductal proliferative lesions: usual ductal hyperplasia, atypical ductal hyperplasia, and ductal carcinoma in situ. In: Biopsy Interpretation of the Breast. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013. p. 78.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melinda F. Lerwill MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Biernacka, A., Lerwill, M.F. (2018). Diagnostic Evaluation of Usual Ductal Hyperplasia and Atypical Ductal Hyperplasia. In: Stolnicu, S., Alvarado-Cabrero, I. (eds) Practical Atlas of Breast Pathology . Springer, Cham. https://doi.org/10.1007/978-3-319-93257-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93257-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93256-9

  • Online ISBN: 978-3-319-93257-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics